AU623109B2 - Amphiregulin: a novel bifunctional growth modulating glycoprotein - Google Patents

Info

Publication number

AU623109B2

AU623109B2 AU28769/89A AU2876989A AU623109B2 AU 623109 B2 AU623109 B2 AU 623109B2 AU 28769/89 A AU28769/89 A AU 28769/89A AU 2876989 A AU2876989 A AU 2876989A AU 623109 B2 AU623109 B2 AU 623109B2

Authority

AU

Australia

Prior art keywords

protein

amphiregulin

human

egf

gag

Prior art date

1988-01-25

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Links

• Espacenet
• Global Dossier
• Discuss

• 108010033760 Amphiregulin Proteins 0.000 title claims description 502
• 102000007299 Amphiregulin Human genes 0.000 title claims description 494
• 230000012010 growth Effects 0.000 title claims description 56
• 230000001588 bifunctional effect Effects 0.000 title claims description 8
• 102000003886 Glycoproteins Human genes 0.000 title description 9
• 108090000288 Glycoproteins Proteins 0.000 title description 9
• 210000004027 cell Anatomy 0.000 claims description 242
• 108090000623 proteins and genes Proteins 0.000 claims description 142
• 102000004169 proteins and genes Human genes 0.000 claims description 97
• 241000282414 Homo sapiens Species 0.000 claims description 82
• 102100033237 Pro-epidermal growth factor Human genes 0.000 claims description 77
• 239000012634 fragment Substances 0.000 claims description 72
• 238000000034 method Methods 0.000 claims description 58
• 239000013612 plasmid Substances 0.000 claims description 58
• 230000000694 effects Effects 0.000 claims description 56
• 239000002299 complementary DNA Substances 0.000 claims description 54
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 45
• 125000003729 nucleotide group Chemical group 0.000 claims description 43
• 239000002773 nucleotide Substances 0.000 claims description 41
• 230000027455 binding Effects 0.000 claims description 39
• 239000002243 precursor Substances 0.000 claims description 39
• 206010028980 Neoplasm Diseases 0.000 claims description 37
• 230000014509 gene expression Effects 0.000 claims description 36
• 108091026890 Coding region Proteins 0.000 claims description 35
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 28
• 238000003556 assay Methods 0.000 claims description 27
• 238000004519 manufacturing process Methods 0.000 claims description 21
• 201000011510 cancer Diseases 0.000 claims description 20
• 210000002950 fibroblast Anatomy 0.000 claims description 20
• 229920002678 cellulose Polymers 0.000 claims description 19
• 238000012360 testing method Methods 0.000 claims description 19
• 241000588724 Escherichia coli Species 0.000 claims description 18
• 239000001913 cellulose Substances 0.000 claims description 18
• 239000002609 medium Substances 0.000 claims description 18
• 101000809450 Homo sapiens Amphiregulin Proteins 0.000 claims description 17
• 108020004999 messenger RNA Proteins 0.000 claims description 17
• 230000001105 regulatory effect Effects 0.000 claims description 17
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 16
• 230000010261 cell growth Effects 0.000 claims description 16
• 238000010348 incorporation Methods 0.000 claims description 16
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
• 210000003953 foreskin Anatomy 0.000 claims description 15
• 238000000338 in vitro Methods 0.000 claims description 15
• 210000000481 breast Anatomy 0.000 claims description 12
• 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 11
• 239000012091 fetal bovine serum Substances 0.000 claims description 11
• 238000002169 hydrotherapy Methods 0.000 claims description 11
• 208000009956 adenocarcinoma Diseases 0.000 claims description 10
• 102000043494 human AREG Human genes 0.000 claims description 10
• 239000003636 conditioned culture medium Substances 0.000 claims description 9
• 239000003795 chemical substances by application Substances 0.000 claims description 8
• 230000001086 cytosolic effect Effects 0.000 claims description 8
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 8
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 7
• 101000836540 Homo sapiens Aldo-keto reductase family 1 member B1 Proteins 0.000 claims description 6
• 101000928259 Homo sapiens NADPH:adrenodoxin oxidoreductase, mitochondrial Proteins 0.000 claims description 6
• 108010079105 Shope fibroma virus growth factor Proteins 0.000 claims description 6
• 125000000539 amino acid group Chemical group 0.000 claims description 6
• 102000046818 human AR Human genes 0.000 claims description 6
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 6
• 230000003612 virological effect Effects 0.000 claims description 6
• 241000283690 Bos taurus Species 0.000 claims description 5
• 101000851176 Homo sapiens Pro-epidermal growth factor Proteins 0.000 claims description 5
• 101710098940 Pro-epidermal growth factor Proteins 0.000 claims description 5
• 230000004663 cell proliferation Effects 0.000 claims description 5
• GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 claims description 5
• 108020001580 protein domains Proteins 0.000 claims description 5
• 108010014173 Factor X Proteins 0.000 claims description 4
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 4
• 208000013013 vulvar carcinoma Diseases 0.000 claims description 4
• 101100074828 Caenorhabditis elegans lin-12 gene Proteins 0.000 claims description 3
• 108010080865 Factor XII Proteins 0.000 claims description 3
• 229930182555 Penicillin Natural products 0.000 claims description 3
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 3
• 101800004937 Protein C Proteins 0.000 claims description 3
• 102000017975 Protein C Human genes 0.000 claims description 3
• 101800001700 Saposin-D Proteins 0.000 claims description 3
• 239000003630 growth substance Substances 0.000 claims description 3
• 229940049954 penicillin Drugs 0.000 claims description 3
• 229960000856 protein c Drugs 0.000 claims description 3
• 229960005322 streptomycin Drugs 0.000 claims description 3
• 102100022641 Coagulation factor IX Human genes 0.000 claims description 2
• 108010076282 Factor IX Proteins 0.000 claims description 2
• 102000000429 Factor XII Human genes 0.000 claims description 2
• 241000244206 Nematoda Species 0.000 claims description 2
• 239000003623 enhancer Substances 0.000 claims description 2
• 229960004222 factor ix Drugs 0.000 claims description 2
• 230000014759 maintenance of location Effects 0.000 claims 11
• 238000012258 culturing Methods 0.000 claims 4
• 239000008186 active pharmaceutical agent Substances 0.000 claims 2
• 108091005608 glycosylated proteins Proteins 0.000 claims 2
• 102000035122 glycosylated proteins Human genes 0.000 claims 2
• 230000017095 negative regulation of cell growth Effects 0.000 claims 2
• 230000035407 negative regulation of cell proliferation Effects 0.000 claims 2
• 230000034918 positive regulation of cell growth Effects 0.000 claims 2
• 230000002285 radioactive effect Effects 0.000 claims 2
• 210000003905 vulva Anatomy 0.000 claims 2
• ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 claims 1
• 101100371648 Caenorhabditis elegans usp-14 gene Proteins 0.000 claims 1
• 102100031605 Dolichol kinase Human genes 0.000 claims 1
• 241000257465 Echinoidea Species 0.000 claims 1
• 101000845698 Homo sapiens Dolichol kinase Proteins 0.000 claims 1
• 241000764238 Isis Species 0.000 claims 1
• 101100449516 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) grg-1 gene Proteins 0.000 claims 1
• 108010066124 Protein S Proteins 0.000 claims 1
• 102000029301 Protein S Human genes 0.000 claims 1
• 229940096437 Protein S Drugs 0.000 claims 1
• 102100029812 Protein S100-A12 Human genes 0.000 claims 1
• 101710110949 Protein S100-A12 Proteins 0.000 claims 1
• 102000007620 Pulmonary Surfactant-Associated Protein C Human genes 0.000 claims 1
• 108010007125 Pulmonary Surfactant-Associated Protein C Proteins 0.000 claims 1
• 101000870345 Vasconcellea cundinamarcensis Cysteine proteinase 1 Proteins 0.000 claims 1
• 239000013256 coordination polymer Substances 0.000 claims 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
• 238000005417 image-selected in vivo spectroscopy Methods 0.000 claims 1
• 238000012739 integrated shape imaging system Methods 0.000 claims 1
• 108010025221 plasma protein Z Proteins 0.000 claims 1
• 101150090882 tgt-1 gene Proteins 0.000 claims 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 76
• 101800003838 Epidermal growth factor Proteins 0.000 description 71
• 229940116977 epidermal growth factor Drugs 0.000 description 70
• 235000018102 proteins Nutrition 0.000 description 67
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 66
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 62
• 108020004414 DNA Proteins 0.000 description 53
• 238000011282 treatment Methods 0.000 description 45
• 235000001014 amino acid Nutrition 0.000 description 39
• 229940024606 amino acid Drugs 0.000 description 36
• 150000001413 amino acids Chemical class 0.000 description 33
• 238000004458 analytical method Methods 0.000 description 31
• 239000003102 growth factor Substances 0.000 description 30
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 29
• 239000000499 gel Substances 0.000 description 29
• 239000000047 product Substances 0.000 description 29
• 239000000523 sample Substances 0.000 description 28
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 25
• 108091034117 Oligonucleotide Proteins 0.000 description 25
• 239000000203 mixture Substances 0.000 description 25
• 102000004196 processed proteins & peptides Human genes 0.000 description 25
• 239000013598 vector Substances 0.000 description 25
• 239000002953 phosphate buffered saline Substances 0.000 description 22
• 101150029129 AR gene Proteins 0.000 description 21
• 102000005962 receptors Human genes 0.000 description 21
• 108020003175 receptors Proteins 0.000 description 21
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 20
• 239000013604 expression vector Substances 0.000 description 20
• 208000027418 Wounds and injury Diseases 0.000 description 18
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 16
• 101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 description 16
• 206010052428 Wound Diseases 0.000 description 16
• 230000002401 inhibitory effect Effects 0.000 description 16
• 206010006187 Breast cancer Diseases 0.000 description 15
• 235000010980 cellulose Nutrition 0.000 description 15
• 239000002904 solvent Substances 0.000 description 15
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 14
• 150000001875 compounds Chemical class 0.000 description 14
• 238000004128 high performance liquid chromatography Methods 0.000 description 14
• 239000006228 supernatant Substances 0.000 description 14
• 102000001301 EGF receptor Human genes 0.000 description 13
• 108060006698 EGF receptor Proteins 0.000 description 13
• 238000009396 hybridization Methods 0.000 description 13
• 239000012528 membrane Substances 0.000 description 13
• 238000013518 transcription Methods 0.000 description 13
• 230000035897 transcription Effects 0.000 description 13
• 102100037571 Neurosecretory protein VGF Human genes 0.000 description 12
• 101800003344 Vaccinia growth factor Proteins 0.000 description 12
• 101800001863 Variola growth factor Proteins 0.000 description 12
• 230000004071 biological effect Effects 0.000 description 12
• 230000006870 function Effects 0.000 description 12
• 238000000746 purification Methods 0.000 description 12
• 108700024394 Exon Proteins 0.000 description 11
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
• -1 amino S 15 Chemical compound 0.000 description 11
• 210000000349 chromosome Anatomy 0.000 description 11
• 238000010367 cloning Methods 0.000 description 11
• 239000000463 material Substances 0.000 description 11
• 239000000243 solution Substances 0.000 description 11
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 10
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
• 241000700605 Viruses Species 0.000 description 10
• 229960000583 acetic acid Drugs 0.000 description 10
• 238000007792 addition Methods 0.000 description 10
• 235000018417 cysteine Nutrition 0.000 description 10
• 238000002360 preparation method Methods 0.000 description 10
• 238000012545 processing Methods 0.000 description 10
• 230000004044 response Effects 0.000 description 10
• 238000013519 translation Methods 0.000 description 10
• 230000014616 translation Effects 0.000 description 10
• 229920001817 Agar Polymers 0.000 description 9
• 208000026310 Breast neoplasm Diseases 0.000 description 9
• 108010070047 Notch Receptors Proteins 0.000 description 9
• 108010055817 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Proteins 0.000 description 9
• 102000000447 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Human genes 0.000 description 9
• 238000012512 characterization method Methods 0.000 description 9
• 238000003776 cleavage reaction Methods 0.000 description 9
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 9
• 230000006698 induction Effects 0.000 description 9
• 239000008188 pellet Substances 0.000 description 9
• 230000007017 scission Effects 0.000 description 9
• 210000001519 tissue Anatomy 0.000 description 9
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 8
• 102000005593 Endopeptidases Human genes 0.000 description 8
• 108010059378 Endopeptidases Proteins 0.000 description 8
• 239000004471 Glycine Substances 0.000 description 8
• 108091092195 Intron Proteins 0.000 description 8
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 8
• 102000011420 Phospholipase D Human genes 0.000 description 8
• 108090000553 Phospholipase D Proteins 0.000 description 8
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
• 239000008272 agar Substances 0.000 description 8
• 235000009582 asparagine Nutrition 0.000 description 8
• 229960001230 asparagine Drugs 0.000 description 8
• 238000003745 diagnosis Methods 0.000 description 8
• 230000005764 inhibitory process Effects 0.000 description 8
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
• 238000002955 isolation Methods 0.000 description 8
• 239000003550 marker Substances 0.000 description 8
• 230000035755 proliferation Effects 0.000 description 8
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
• 230000000638 stimulation Effects 0.000 description 8
• 230000006820 DNA synthesis Effects 0.000 description 7
• 238000002965 ELISA Methods 0.000 description 7
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 7
• 239000000020 Nitrocellulose Substances 0.000 description 7
• 102000014736 Notch Human genes 0.000 description 7
• 108091028043 Nucleic acid sequence Proteins 0.000 description 7
• 108010009583 Transforming Growth Factors Proteins 0.000 description 7
• 102000009618 Transforming Growth Factors Human genes 0.000 description 7
• 239000000872 buffer Substances 0.000 description 7
• 238000006243 chemical reaction Methods 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 229920001220 nitrocellulos Polymers 0.000 description 7
• 239000012071 phase Substances 0.000 description 7
• 230000009467 reduction Effects 0.000 description 7
• 238000004007 reversed phase HPLC Methods 0.000 description 7
• 230000035945 sensitivity Effects 0.000 description 7
• 235000004400 serine Nutrition 0.000 description 7
• 206010041823 squamous cell carcinoma Diseases 0.000 description 7
• 230000004936 stimulating effect Effects 0.000 description 7
• 239000012588 trypsin Substances 0.000 description 7
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 6
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 6
• 108090000790 Enzymes Proteins 0.000 description 6
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 6
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
• 108010030544 Peptidyl-Lys metalloendopeptidase Proteins 0.000 description 6
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
• 108091081024 Start codon Proteins 0.000 description 6
• 239000007983 Tris buffer Substances 0.000 description 6
• 108090000631 Trypsin Proteins 0.000 description 6
• 102000004142 Trypsin Human genes 0.000 description 6
• 239000002253 acid Substances 0.000 description 6
• 238000013459 approach Methods 0.000 description 6
• YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 239000003114 blood coagulation factor Substances 0.000 description 6
• 230000004069 differentiation Effects 0.000 description 6
• 230000029087 digestion Effects 0.000 description 6
• 229940088598 enzyme Drugs 0.000 description 6
• 238000005227 gel permeation chromatography Methods 0.000 description 6
• 239000000411 inducer Substances 0.000 description 6
• 238000003780 insertion Methods 0.000 description 6
• 230000037431 insertion Effects 0.000 description 6
• 239000003446 ligand Substances 0.000 description 6
• 230000007246 mechanism Effects 0.000 description 6
• 229920001184 polypeptide Polymers 0.000 description 6
• 235000013930 proline Nutrition 0.000 description 6
• 239000011780 sodium chloride Substances 0.000 description 6
• 230000002103 transcriptional effect Effects 0.000 description 6
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
• 210000004881 tumor cell Anatomy 0.000 description 6
• 239000003643 water by type Substances 0.000 description 6
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
• 229920000936 Agarose Polymers 0.000 description 5
• 201000009030 Carcinoma Diseases 0.000 description 5
• 108020004705 Codon Proteins 0.000 description 5
• 108091035707 Consensus sequence Proteins 0.000 description 5
• 241000701022 Cytomegalovirus Species 0.000 description 5
• 238000000636 Northern blotting Methods 0.000 description 5
• 108700026244 Open Reading Frames Proteins 0.000 description 5
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 5
• 210000004556 brain Anatomy 0.000 description 5
• 201000008274 breast adenocarcinoma Diseases 0.000 description 5
• 201000008275 breast carcinoma Diseases 0.000 description 5
• 238000004587 chromatography analysis Methods 0.000 description 5
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
• 238000001514 detection method Methods 0.000 description 5
• 238000010790 dilution Methods 0.000 description 5
• 239000012895 dilution Substances 0.000 description 5
• 231100000673 dose–response relationship Toxicity 0.000 description 5
• 230000013595 glycosylation Effects 0.000 description 5
• 238000006206 glycosylation reaction Methods 0.000 description 5
• 210000003734 kidney Anatomy 0.000 description 5
• 239000012160 loading buffer Substances 0.000 description 5
• 210000004072 lung Anatomy 0.000 description 5
• 230000004048 modification Effects 0.000 description 5
• 238000012986 modification Methods 0.000 description 5
• 230000009826 neoplastic cell growth Effects 0.000 description 5
• 230000008488 polyadenylation Effects 0.000 description 5
• 238000004393 prognosis Methods 0.000 description 5
• 238000003127 radioimmunoassay Methods 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 230000028327 secretion Effects 0.000 description 5
• 239000004017 serum-free culture medium Substances 0.000 description 5
• 239000007790 solid phase Substances 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 238000006467 substitution reaction Methods 0.000 description 5
• 230000008685 targeting Effects 0.000 description 5
• 235000008521 threonine Nutrition 0.000 description 5
• 238000001262 western blot Methods 0.000 description 5
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
• 239000004475 Arginine Substances 0.000 description 4
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
• 101150074155 DHFR gene Proteins 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• 108700005087 Homeobox Genes Proteins 0.000 description 4
• 102000004877 Insulin Human genes 0.000 description 4
• 108090001061 Insulin Proteins 0.000 description 4
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
• 241000699666 Mus <mouse, genus> Species 0.000 description 4
• SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 4
• 108010006232 Neuraminidase Proteins 0.000 description 4
• 102000005348 Neuraminidase Human genes 0.000 description 4
• 102000035195 Peptidases Human genes 0.000 description 4
• 108091005804 Peptidases Proteins 0.000 description 4
• 101710182846 Polyhedrin Proteins 0.000 description 4
• 239000004365 Protease Substances 0.000 description 4
• 241000700159 Rattus Species 0.000 description 4
• 108020004511 Recombinant DNA Proteins 0.000 description 4
• 238000012300 Sequence Analysis Methods 0.000 description 4
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
• 108091036066 Three prime untranslated region Proteins 0.000 description 4
• 235000004279 alanine Nutrition 0.000 description 4
• 230000004075 alteration Effects 0.000 description 4
• 230000001028 anti-proliverative effect Effects 0.000 description 4
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
• 235000003704 aspartic acid Nutrition 0.000 description 4
• 210000003719 b-lymphocyte Anatomy 0.000 description 4
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
• 230000033228 biological regulation Effects 0.000 description 4
• 210000004899 c-terminal region Anatomy 0.000 description 4
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
• 239000004202 carbamide Substances 0.000 description 4
• 230000015556 catabolic process Effects 0.000 description 4
• 230000002759 chromosomal effect Effects 0.000 description 4
• 238000012217 deletion Methods 0.000 description 4
• 230000037430 deletion Effects 0.000 description 4
• 239000003814 drug Substances 0.000 description 4
• 238000010828 elution Methods 0.000 description 4
• 230000002255 enzymatic effect Effects 0.000 description 4
• 239000000284 extract Substances 0.000 description 4
• 235000013922 glutamic acid Nutrition 0.000 description 4
• 239000004220 glutamic acid Substances 0.000 description 4
• 230000028993 immune response Effects 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 229940125396 insulin Drugs 0.000 description 4
• 230000031864 metaphase Effects 0.000 description 4
• 210000004940 nucleus Anatomy 0.000 description 4
• 210000001672 ovary Anatomy 0.000 description 4
• 238000003752 polymerase chain reaction Methods 0.000 description 4
• 230000003389 potentiating effect Effects 0.000 description 4
• 239000013615 primer Substances 0.000 description 4
• 230000006337 proteolytic cleavage Effects 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 238000012163 sequencing technique Methods 0.000 description 4
• 239000000758 substrate Substances 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
• 241000701161 unidentified adenovirus Species 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 description 3
• HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 3
• 208000003200 Adenoma Diseases 0.000 description 3
• 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 3
• 102000003846 Carbonic anhydrases Human genes 0.000 description 3
• 108090000209 Carbonic anhydrases Proteins 0.000 description 3
• 108020004635 Complementary DNA Proteins 0.000 description 3
• 102000012410 DNA Ligases Human genes 0.000 description 3
• 108010061982 DNA Ligases Proteins 0.000 description 3
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
• 241001131785 Escherichia coli HB101 Species 0.000 description 3
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
• 244000068988 Glycine max Species 0.000 description 3
• 235000010469 Glycine max Nutrition 0.000 description 3
• 241000238631 Hexapoda Species 0.000 description 3
• 101100055553 Homo sapiens AR gene Proteins 0.000 description 3
• 101710177504 Kit ligand Proteins 0.000 description 3
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
• 239000004472 Lysine Substances 0.000 description 3
• LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
• 230000004988 N-glycosylation Effects 0.000 description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 description 3
• 102000004211 Platelet factor 4 Human genes 0.000 description 3
• 108090000778 Platelet factor 4 Proteins 0.000 description 3
• 108091036407 Polyadenylation Proteins 0.000 description 3
• 239000004743 Polypropylene Substances 0.000 description 3
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
• 102000001253 Protein Kinase Human genes 0.000 description 3
• 102000003923 Protein Kinase C Human genes 0.000 description 3
• 108090000315 Protein Kinase C Proteins 0.000 description 3
• 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 3
• 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 3
• 108091034057 RNA (poly(A)) Proteins 0.000 description 3
• 229920002684 Sepharose Polymers 0.000 description 3
• 210000001744 T-lymphocyte Anatomy 0.000 description 3
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
• 239000004473 Threonine Substances 0.000 description 3
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
• 229920004890 Triton X-100 Polymers 0.000 description 3
• 239000013504 Triton X-100 Substances 0.000 description 3
• 101710162629 Trypsin inhibitor Proteins 0.000 description 3
• 229940122618 Trypsin inhibitor Drugs 0.000 description 3
• 206010046865 Vaccinia virus infection Diseases 0.000 description 3
• 239000011543 agarose gel Substances 0.000 description 3
• 229940114079 arachidonic acid Drugs 0.000 description 3
• 235000021342 arachidonic acid Nutrition 0.000 description 3
• 230000003305 autocrine Effects 0.000 description 3
• 150000001720 carbohydrates Chemical class 0.000 description 3
• 230000011712 cell development Effects 0.000 description 3
• 230000024245 cell differentiation Effects 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 230000005757 colony formation Effects 0.000 description 3
• 230000001143 conditioned effect Effects 0.000 description 3
• 238000010276 construction Methods 0.000 description 3
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical class BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
• 230000002559 cytogenic effect Effects 0.000 description 3
• 238000006731 degradation reaction Methods 0.000 description 3
• IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 3
• 230000004927 fusion Effects 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 210000005260 human cell Anatomy 0.000 description 3
• 238000003018 immunoassay Methods 0.000 description 3
• 230000000977 initiatory effect Effects 0.000 description 3
• 208000014674 injury Diseases 0.000 description 3
• 238000011081 inoculation Methods 0.000 description 3
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
• 229960000310 isoleucine Drugs 0.000 description 3
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 3
• 230000003211 malignant effect Effects 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 230000005012 migration Effects 0.000 description 3
• 238000013508 migration Methods 0.000 description 3
• 238000012544 monitoring process Methods 0.000 description 3
• 210000005170 neoplastic cell Anatomy 0.000 description 3
• 229910052757 nitrogen Inorganic materials 0.000 description 3
• 230000030648 nucleus localization Effects 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 201000010148 papillary adenoma Diseases 0.000 description 3
• 230000037361 pathway Effects 0.000 description 3
• 229920002401 polyacrylamide Polymers 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 230000002062 proliferating effect Effects 0.000 description 3
• 150000003148 prolines Chemical class 0.000 description 3
• 235000019419 proteases Nutrition 0.000 description 3
• 238000000159 protein binding assay Methods 0.000 description 3
• 108060006633 protein kinase Proteins 0.000 description 3
• 238000003156 radioimmunoprecipitation Methods 0.000 description 3
• 239000011541 reaction mixture Substances 0.000 description 3
• 230000006798 recombination Effects 0.000 description 3
• 230000001177 retroviral effect Effects 0.000 description 3
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 3
• 239000001632 sodium acetate Substances 0.000 description 3
• 235000017281 sodium acetate Nutrition 0.000 description 3
• 241000894007 species Species 0.000 description 3
• LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 3
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 3
• 230000005945 translocation Effects 0.000 description 3
• 239000002753 trypsin inhibitor Substances 0.000 description 3
• 208000007089 vaccinia Diseases 0.000 description 3
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• 108020005029 5' Flanking Region Proteins 0.000 description 2
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
• 208000036832 Adenocarcinoma of ovary Diseases 0.000 description 2
• 241000972773 Aulopiformes Species 0.000 description 2
• 102100023995 Beta-nerve growth factor Human genes 0.000 description 2
• 208000006386 Bone Resorption Diseases 0.000 description 2
• 241000282552 Chlorocebus aethiops Species 0.000 description 2
• 208000006332 Choriocarcinoma Diseases 0.000 description 2
• 108010038061 Chymotrypsinogen Proteins 0.000 description 2
• 208000030808 Clear cell renal carcinoma Diseases 0.000 description 2
• 108700010070 Codon Usage Proteins 0.000 description 2
• 241000699800 Cricetinae Species 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 239000003155 DNA primer Substances 0.000 description 2
• 238000001712 DNA sequencing Methods 0.000 description 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
• 101150084418 EGF gene Proteins 0.000 description 2
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
• OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
• 102000020897 Formins Human genes 0.000 description 2
• 108091022623 Formins Proteins 0.000 description 2
• 108010051815 Glutamyl endopeptidase Proteins 0.000 description 2
• 102000009465 Growth Factor Receptors Human genes 0.000 description 2
• 108010009202 Growth Factor Receptors Proteins 0.000 description 2
• 101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 description 2
• 102100034343 Integrase Human genes 0.000 description 2
• 102000014150 Interferons Human genes 0.000 description 2
• 108010050904 Interferons Proteins 0.000 description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
• 108010001831 LDL receptors Proteins 0.000 description 2
• 101710128836 Large T antigen Proteins 0.000 description 2
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
• 102000004882 Lipase Human genes 0.000 description 2
• 108090001060 Lipase Proteins 0.000 description 2
• 239000004367 Lipase Substances 0.000 description 2
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 2
• 108010074338 Lymphokines Proteins 0.000 description 2
• 102000008072 Lymphokines Human genes 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 101100278853 Mus musculus Dhfr gene Proteins 0.000 description 2
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 2
• 108010025020 Nerve Growth Factor Proteins 0.000 description 2
• 102000004140 Oncostatin M Human genes 0.000 description 2
• 108090000630 Oncostatin M Proteins 0.000 description 2
• 102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 2
• 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 2
• 108010058846 Ovalbumin Proteins 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 241000609499 Palicourea Species 0.000 description 2
• 102100026918 Phospholipase A2 Human genes 0.000 description 2
• 108010058864 Phospholipases A2 Proteins 0.000 description 2
• 108091000080 Phosphotransferase Proteins 0.000 description 2
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
• 108091006629 SLC13A2 Proteins 0.000 description 2
• 229920005654 Sephadex Polymers 0.000 description 2
• 239000012507 Sephadex™ Substances 0.000 description 2
• 238000002105 Southern blotting Methods 0.000 description 2
• 241000256251 Spodoptera frugiperda Species 0.000 description 2
• 208000002847 Surgical Wound Diseases 0.000 description 2
• UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 2
• NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
• 239000007997 Tricine buffer Substances 0.000 description 2
• 206010054094 Tumour necrosis Diseases 0.000 description 2
• 102000014384 Type C Phospholipases Human genes 0.000 description 2
• 108010079194 Type C Phospholipases Proteins 0.000 description 2
• 208000025865 Ulcer Diseases 0.000 description 2
• 108091023045 Untranslated Region Proteins 0.000 description 2
• 241000700618 Vaccinia virus Species 0.000 description 2
• 101710179590 Vitamin D-binding protein Proteins 0.000 description 2
• RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 108060000200 adenylate cyclase Proteins 0.000 description 2
• 102000030621 adenylate cyclase Human genes 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 230000003321 amplification Effects 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 230000000975 bioactive effect Effects 0.000 description 2
• 229940019700 blood coagulation factors Drugs 0.000 description 2
• 230000024279 bone resorption Effects 0.000 description 2
• 239000007853 buffer solution Substances 0.000 description 2
• 238000010804 cDNA synthesis Methods 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 244000309466 calf Species 0.000 description 2
• 229910002091 carbon monoxide Inorganic materials 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 101150055766 cat gene Proteins 0.000 description 2
• 208000019065 cervical carcinoma Diseases 0.000 description 2
• VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 239000013599 cloning vector Substances 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 239000012141 concentrate Substances 0.000 description 2
• 239000006071 cream Substances 0.000 description 2
• SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
• SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
• HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 238000000502 dialysis Methods 0.000 description 2
• KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 2
• 230000003292 diminished effect Effects 0.000 description 2
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 210000002889 endothelial cell Anatomy 0.000 description 2
• 230000001076 estrogenic effect Effects 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 229940126864 fibroblast growth factor Drugs 0.000 description 2
• 239000012737 fresh medium Substances 0.000 description 2
• 108010026195 glycanase Proteins 0.000 description 2
• 230000009036 growth inhibition Effects 0.000 description 2
• 239000003966 growth inhibitor Substances 0.000 description 2
• 230000035876 healing Effects 0.000 description 2
• 238000003505 heat denaturation Methods 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
• 229960000027 human factor ix Drugs 0.000 description 2
• 210000004408 hybridoma Anatomy 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 230000016784 immunoglobulin production Effects 0.000 description 2
• 238000007901 in situ hybridization Methods 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 238000001155 isoelectric focusing Methods 0.000 description 2
• 210000003292 kidney cell Anatomy 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 101150063692 lin-12 gene Proteins 0.000 description 2
• 235000019421 lipase Nutrition 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 201000001441 melanoma Diseases 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
• 229930182817 methionine Natural products 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 230000002297 mitogenic effect Effects 0.000 description 2
• 229940053128 nerve growth factor Drugs 0.000 description 2
• 230000001537 neural effect Effects 0.000 description 2
• 238000003199 nucleic acid amplification method Methods 0.000 description 2
• 102000039446 nucleic acids Human genes 0.000 description 2
• 108020004707 nucleic acids Proteins 0.000 description 2
• 150000007523 nucleic acids Chemical class 0.000 description 2
• 230000008520 organization Effects 0.000 description 2
• 229940092253 ovalbumin Drugs 0.000 description 2
• 230000002611 ovarian Effects 0.000 description 2
• 208000013371 ovarian adenocarcinoma Diseases 0.000 description 2
• 230000003647 oxidation Effects 0.000 description 2
• 238000007254 oxidation reaction Methods 0.000 description 2
• 238000004806 packaging method and process Methods 0.000 description 2
• 210000000496 pancreas Anatomy 0.000 description 2
• 238000010647 peptide synthesis reaction Methods 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 235000021317 phosphate Nutrition 0.000 description 2
• 150000003904 phospholipids Chemical class 0.000 description 2
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 102000020233 phosphotransferase Human genes 0.000 description 2
• 210000002826 placenta Anatomy 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229920001155 polypropylene Polymers 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 230000001737 promoting effect Effects 0.000 description 2
• 230000002797 proteolythic effect Effects 0.000 description 2
• 101150079601 recA gene Proteins 0.000 description 2
• 238000005215 recombination Methods 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 108091008146 restriction endonucleases Proteins 0.000 description 2
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
• 235000019515 salmon Nutrition 0.000 description 2
• 150000003355 serines Chemical class 0.000 description 2
• 239000012679 serum free medium Substances 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 238000010583 slow cooling Methods 0.000 description 2
• JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 230000002195 synergetic effect Effects 0.000 description 2
• 208000001608 teratocarcinoma Diseases 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 210000001541 thymus gland Anatomy 0.000 description 2
• 230000017423 tissue regeneration Effects 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 230000009466 transformation Effects 0.000 description 2
• 230000001131 transforming effect Effects 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• 230000006107 tyrosine sulfation Effects 0.000 description 2
• 231100000397 ulcer Toxicity 0.000 description 2
• 241000701447 unidentified baculovirus Species 0.000 description 2
• 241001515965 unidentified phage Species 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• WZPJZJQDNCHIOT-YTLIFORHSA-N (2s)-2-amino-3-hydroxypropanoic acid;(2s)-2-amino-3-phenylpropanoic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound OC[C@H](N)C(O)=O.OC(=O)[C@@H]1CCCN1.OC(=O)[C@@H](N)CC1=CC=CC=C1 WZPJZJQDNCHIOT-YTLIFORHSA-N 0.000 description 1
• WZEJGSYLAFXHCK-YQVWRLOYSA-N (2s)-2-amino-n-[2-[[(1r,2r)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]amino]acetyl]-3-phenylpropanamide Chemical compound C([C@H](N)C(=O)NC(=O)CN[C@H](CO)[C@H](O)C=1C=CC(=CC=1)[N+]([O-])=O)C1=CC=CC=C1 WZEJGSYLAFXHCK-YQVWRLOYSA-N 0.000 description 1
• JFOWDKWFHZIMTR-RUCXOUQFSA-N (2s)-2-aminopentanedioic acid;(2s)-2,5-diamino-5-oxopentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(N)=O.OC(=O)[C@@H](N)CCC(O)=O JFOWDKWFHZIMTR-RUCXOUQFSA-N 0.000 description 1
• ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
• VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
• UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical class O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
• 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
• 102100027211 Albumin Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
• 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
• 108010039627 Aprotinin Proteins 0.000 description 1
• 101100215738 Arabidopsis thaliana ABF2 gene Proteins 0.000 description 1
• 208000002109 Argyria Diseases 0.000 description 1
• 102100023190 Armadillo repeat-containing protein 1 Human genes 0.000 description 1
• 102100030907 Aryl hydrocarbon receptor nuclear translocator Human genes 0.000 description 1
• FRYULLIZUDQONW-IMJSIDKUSA-N Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FRYULLIZUDQONW-IMJSIDKUSA-N 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 244000056139 Brassica cretica Species 0.000 description 1
• 235000003351 Brassica cretica Nutrition 0.000 description 1
• 240000007124 Brassica oleracea Species 0.000 description 1
• 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
• 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
• 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
• 235000003343 Brassica rupestris Nutrition 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 101000690445 Caenorhabditis elegans Aryl hydrocarbon receptor nuclear translocator homolog Proteins 0.000 description 1
• 101100135641 Caenorhabditis elegans par-3 gene Proteins 0.000 description 1
• 101100489581 Caenorhabditis elegans par-5 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241000283153 Cetacea Species 0.000 description 1
• 102100037355 Chromosome alignment-maintaining phosphoprotein 1 Human genes 0.000 description 1
• 208000017667 Chronic Disease Diseases 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
• 108090000056 Complement factor B Proteins 0.000 description 1
• 102000003712 Complement factor B Human genes 0.000 description 1
• 206010010356 Congenital anomaly Diseases 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
• 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
• 102000018832 Cytochromes Human genes 0.000 description 1
• 108010052832 Cytochromes Proteins 0.000 description 1
• 102000010831 Cytoskeletal Proteins Human genes 0.000 description 1
• 108010037414 Cytoskeletal Proteins Proteins 0.000 description 1
• 108010017826 DNA Polymerase I Proteins 0.000 description 1
• 102000004594 DNA Polymerase I Human genes 0.000 description 1
• 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
• 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 1
• 239000003298 DNA probe Substances 0.000 description 1
• 238000007900 DNA-DNA hybridization Methods 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 108010092160 Dactinomycin Proteins 0.000 description 1
• SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
• 206010056340 Diabetic ulcer Diseases 0.000 description 1
• 102100024746 Dihydrofolate reductase Human genes 0.000 description 1
• 108010016626 Dipeptides Proteins 0.000 description 1
• 108700007800 Drosophila N Proteins 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 102000003951 Erythropoietin Human genes 0.000 description 1
• 108090000394 Erythropoietin Proteins 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• 102000018389 Exopeptidases Human genes 0.000 description 1
• 108010091443 Exopeptidases Proteins 0.000 description 1
• RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
• 102000008857 Ferritin Human genes 0.000 description 1
• 108050000784 Ferritin Proteins 0.000 description 1
• 238000008416 Ferritin Methods 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical group NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 1
• 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 1
• 206010073069 Hepatic cancer Diseases 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 102000006947 Histones Human genes 0.000 description 1
• 108010033040 Histones Proteins 0.000 description 1
• 101100002445 Homo sapiens ARMC1 gene Proteins 0.000 description 1
• 101000793115 Homo sapiens Aryl hydrocarbon receptor nuclear translocator Proteins 0.000 description 1
• 101000741320 Homo sapiens Cathelicidin antimicrobial peptide Proteins 0.000 description 1
• 101000880066 Homo sapiens Chromosome alignment-maintaining phosphoprotein 1 Proteins 0.000 description 1
• 101001062763 Homo sapiens Coagulation factor XII Proteins 0.000 description 1
• 101100118554 Homo sapiens EGF gene Proteins 0.000 description 1
• 101001022170 Homo sapiens FYN-binding protein 2 Proteins 0.000 description 1
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 1
• 101000990990 Homo sapiens Midkine Proteins 0.000 description 1
• 101000605403 Homo sapiens Plasminogen Proteins 0.000 description 1
• 101000621344 Homo sapiens Protein Wnt-2 Proteins 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 206010062016 Immunosuppression Diseases 0.000 description 1
• 208000026350 Inborn Genetic disease Diseases 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 108020005350 Initiator Codon Proteins 0.000 description 1
• 102000003746 Insulin Receptor Human genes 0.000 description 1
• 108010001127 Insulin Receptor Proteins 0.000 description 1
• 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
• 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
• 101710203526 Integrase Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 102100020880 Kit ligand Human genes 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 102000007330 LDL Lipoproteins Human genes 0.000 description 1
• 102000008192 Lactoglobulins Human genes 0.000 description 1
• 108010060630 Lactoglobulins Proteins 0.000 description 1
• 239000004166 Lanolin Substances 0.000 description 1
• 206010023825 Laryngeal cancer Diseases 0.000 description 1
• 241000880493 Leptailurus serval Species 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
• 108090000301 Membrane transport proteins Proteins 0.000 description 1
• 102000003939 Membrane transport proteins Human genes 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 102100030335 Midkine Human genes 0.000 description 1
• 241000713869 Moloney murine leukemia virus Species 0.000 description 1
• 241000713862 Moloney murine sarcoma virus Species 0.000 description 1
• 108010014251 Muramidase Proteins 0.000 description 1
• 102000016943 Muramidase Human genes 0.000 description 1
• 101000966481 Mus musculus Dihydrofolate reductase Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 102100030856 Myoglobin Human genes 0.000 description 1
• 108010062374 Myoglobin Proteins 0.000 description 1
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
• MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
• 229910017974 NH40H Inorganic materials 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 102000007999 Nuclear Proteins Human genes 0.000 description 1
• 108010089610 Nuclear Proteins Proteins 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 102000002488 Nucleoplasmin Human genes 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 101150057876 OTC gene Proteins 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 101100165744 Oryza sativa subsp. japonica BZIP23 gene Proteins 0.000 description 1
• 206010061328 Ovarian epithelial cancer Diseases 0.000 description 1
• 101100313401 Ovis aries TGFA gene Proteins 0.000 description 1
• 108091008606 PDGF receptors Proteins 0.000 description 1
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 101150034459 Parpbp gene Proteins 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 102000015439 Phospholipases Human genes 0.000 description 1
• 108010064785 Phospholipases Proteins 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• 108010065081 Phosphorylase b Proteins 0.000 description 1
• 108010053210 Phycocyanin Proteins 0.000 description 1
• 108010047620 Phytohemagglutinins Proteins 0.000 description 1
• 208000012641 Pigmentation disease Diseases 0.000 description 1
• 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
• 102000001938 Plasminogen Activators Human genes 0.000 description 1
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
• 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
• 241001505332 Polyomavirus sp. Species 0.000 description 1
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 101710149951 Protein Tat Proteins 0.000 description 1
• 102100022805 Protein Wnt-2 Human genes 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 108700020978 Proto-Oncogene Proteins 0.000 description 1
• 102000052575 Proto-Oncogene Human genes 0.000 description 1
• KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
• 102000013009 Pyruvate Kinase Human genes 0.000 description 1
• 108020005115 Pyruvate Kinase Proteins 0.000 description 1
• 230000012153 RNA destabilization Effects 0.000 description 1
• 230000006819 RNA synthesis Effects 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 101000890996 Rattus norvegicus Fibronectin Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 108010073443 Ribi adjuvant Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 241000220317 Rosa Species 0.000 description 1
• 108010029987 Salivary Proteins and Peptides Proteins 0.000 description 1
• 102000001848 Salivary Proteins and Peptides Human genes 0.000 description 1
• PBUXMVYWOSKHMF-WDSKDSINSA-N Ser-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO PBUXMVYWOSKHMF-WDSKDSINSA-N 0.000 description 1
• ILVGMCVCQBJPSH-WDSKDSINSA-N Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO ILVGMCVCQBJPSH-WDSKDSINSA-N 0.000 description 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 101710185500 Small t antigen Proteins 0.000 description 1
• 101100289792 Squirrel monkey polyomavirus large T gene Proteins 0.000 description 1
• 102000014284 Statherin Human genes 0.000 description 1
• 108050003162 Statherin Proteins 0.000 description 1
• 241000258128 Strongylocentrotus purpuratus Species 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 208000004062 Tumor Virus Infections Diseases 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• KRNYOVHEKOBTEF-YUMQZZPRSA-N Val-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(O)=O KRNYOVHEKOBTEF-YUMQZZPRSA-N 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 241000812633 Varicus Species 0.000 description 1
• 102000050760 Vitamin D-binding protein Human genes 0.000 description 1
• 102100038611 Vitamin D-binding protein Human genes 0.000 description 1
• 208000025337 Vulvar squamous cell carcinoma Diseases 0.000 description 1
• 208000008383 Wilms tumor Diseases 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 238000005299 abrasion Methods 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical group C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 238000001261 affinity purification Methods 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 108010047495 alanylglycine Proteins 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
• 239000001099 ammonium carbonate Substances 0.000 description 1
• 239000000908 ammonium hydroxide Substances 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000118 anti-neoplastic effect Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 229940034982 antineoplastic agent Drugs 0.000 description 1
• 229960004405 aprotinin Drugs 0.000 description 1
• 229940003587 aquaphor Drugs 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
• 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 230000035578 autophosphorylation Effects 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 238000009835 boiling Methods 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 210000005013 brain tissue Anatomy 0.000 description 1
• 208000014581 breast ductal adenocarcinoma Diseases 0.000 description 1
• 201000010983 breast ductal carcinoma Diseases 0.000 description 1
• UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
• WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 230000023402 cell communication Effects 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 230000010001 cellular homeostasis Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 210000003679 cervix uteri Anatomy 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 229960005091 chloramphenicol Drugs 0.000 description 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
• 206010073251 clear cell renal cell carcinoma Diseases 0.000 description 1
• 238000012411 cloning technique Methods 0.000 description 1
• 230000008045 co-localization Effects 0.000 description 1
• OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 229940047120 colony stimulating factors Drugs 0.000 description 1
• 239000003184 complementary RNA Substances 0.000 description 1
• 101150054175 cro gene Proteins 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
• 229960000640 dactinomycin Drugs 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 239000007857 degradation product Substances 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 239000000032 diagnostic agent Substances 0.000 description 1
• 229940039227 diagnostic agent Drugs 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 230000009699 differential effect Effects 0.000 description 1
• 108020001096 dihydrofolate reductase Proteins 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 201000010099 disease Diseases 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 230000002900 effect on cell Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 230000013020 embryo development Effects 0.000 description 1
• 229940066758 endopeptidases Drugs 0.000 description 1
• 230000008556 epithelial cell proliferation Effects 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• 238000000855 fermentation Methods 0.000 description 1
• 230000004151 fermentation Effects 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 210000002458 fetal heart Anatomy 0.000 description 1
• 206010016629 fibroma Diseases 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 235000019253 formic acid Nutrition 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 230000022244 formylation Effects 0.000 description 1
• 238000006170 formylation reaction Methods 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 208000016361 genetic disease Diseases 0.000 description 1
• 210000004392 genitalia Anatomy 0.000 description 1
• 239000012362 glacial acetic acid Substances 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 108010085617 glycopeptide alpha-N-acetylgalactosaminidase Proteins 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 108060003552 hemocyanin Proteins 0.000 description 1
• 230000011132 hemopoiesis Effects 0.000 description 1
• 239000008241 heterogeneous mixture Substances 0.000 description 1
• IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical group CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 210000003917 human chromosome Anatomy 0.000 description 1
• 229940100689 human protein c Drugs 0.000 description 1
• 210000004754 hybrid cell Anatomy 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 230000003100 immobilizing effect Effects 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 238000010324 immunological assay Methods 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
• 239000003999 initiator Substances 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 230000035992 intercellular communication Effects 0.000 description 1
• 230000008611 intercellular interaction Effects 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 230000010262 intracellular communication Effects 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 230000037041 intracellular level Effects 0.000 description 1
• 206010073095 invasive ductal breast carcinoma Diseases 0.000 description 1
• 230000026045 iodination Effects 0.000 description 1
• 238000006192 iodination reaction Methods 0.000 description 1
• 238000005342 ion exchange Methods 0.000 description 1
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 229940039717 lanolin Drugs 0.000 description 1
• 235000019388 lanolin Nutrition 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 201000005264 laryngeal carcinoma Diseases 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 108010002060 leukoregulin Proteins 0.000 description 1
• 150000002617 leukotrienes Chemical class 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 210000005228 liver tissue Anatomy 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 210000003141 lower extremity Anatomy 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 230000000527 lymphocytic effect Effects 0.000 description 1
• 239000004325 lysozyme Substances 0.000 description 1
• 229960000274 lysozyme Drugs 0.000 description 1
• 235000010335 lysozyme Nutrition 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 210000003866 melanoblast Anatomy 0.000 description 1
• 230000009061 membrane transport Effects 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 239000003226 mitogen Substances 0.000 description 1
• 230000008747 mitogenic response Effects 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 230000004660 morphological change Effects 0.000 description 1
• 210000000214 mouth Anatomy 0.000 description 1
• 230000004118 muscle contraction Effects 0.000 description 1
• 235000010460 mustard Nutrition 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 208000009091 myxoma Diseases 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 210000003757 neuroblast Anatomy 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 238000011587 new zealand white rabbit Methods 0.000 description 1
• JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
• 108091027963 non-coding RNA Proteins 0.000 description 1
• 102000042567 non-coding RNA Human genes 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 108060005597 nucleoplasmin Proteins 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 239000003883 ointment base Substances 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical group 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 201000006588 ovary adenocarcinoma Diseases 0.000 description 1
• 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
• 210000004923 pancreatic tissue Anatomy 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 230000003076 paracrine Effects 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 230000009054 pathological process Effects 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 239000000863 peptide conjugate Substances 0.000 description 1
• KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
• QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 1
• 150000004633 phorbol derivatives Chemical class 0.000 description 1
• 239000002644 phorbol ester Substances 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 238000003566 phosphorylation assay Methods 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 230000001885 phytohemagglutinin Effects 0.000 description 1
• 201000009442 piebaldism Diseases 0.000 description 1
• 208000010916 pituitary tumor Diseases 0.000 description 1
• 229940127126 plasminogen activator Drugs 0.000 description 1
• 230000004983 pleiotropic effect Effects 0.000 description 1
• 229920001983 poloxamer Polymers 0.000 description 1
• 229920000447 polyanionic polymer Polymers 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 239000004800 polyvinyl chloride Substances 0.000 description 1
• 229920000915 polyvinyl chloride Polymers 0.000 description 1
• 238000010837 poor prognosis Methods 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 230000009696 proliferative response Effects 0.000 description 1
• 150000003815 prostacyclins Chemical class 0.000 description 1
• 150000003180 prostaglandins Chemical class 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 201000005825 prostate adenocarcinoma Diseases 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 230000009822 protein phosphorylation Effects 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
• 239000011535 reaction buffer Substances 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 238000001525 receptor binding assay Methods 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 230000023252 regulation of cell development Effects 0.000 description 1
• 230000021014 regulation of cell growth Effects 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 210000005084 renal tissue Anatomy 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000013606 secretion vector Substances 0.000 description 1
• 210000002955 secretory cell Anatomy 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 108010071207 serylmethionine Proteins 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 239000000741 silica gel Substances 0.000 description 1
• 229910002027 silica gel Inorganic materials 0.000 description 1
• 229940099261 silvadene Drugs 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• FRGKKTITADJNOE-UHFFFAOYSA-N sulfanyloxyethane Chemical compound CCOS FRGKKTITADJNOE-UHFFFAOYSA-N 0.000 description 1
• 230000019635 sulfation Effects 0.000 description 1
• 238000005670 sulfation reaction Methods 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000000946 synaptic effect Effects 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 229960001603 tamoxifen Drugs 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 150000003595 thromboxanes Chemical class 0.000 description 1
• 230000030968 tissue homeostasis Effects 0.000 description 1
• 230000007838 tissue remodeling Effects 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000010474 transient expression Effects 0.000 description 1
• 102000035160 transmembrane proteins Human genes 0.000 description 1
• 108091005703 transmembrane proteins Proteins 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 230000000472 traumatic effect Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 230000001228 trophic effect Effects 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 102000003390 tumor necrosis factor Human genes 0.000 description 1
• 239000000717 tumor promoter Substances 0.000 description 1
• 108091005993 tyrosine-sulfated proteins Proteins 0.000 description 1
• 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 238000000108 ultra-filtration Methods 0.000 description 1
• 230000002485 urinary effect Effects 0.000 description 1
• 108010021889 valylvaline Proteins 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• MTZBBNMLMNBNJL-UHFFFAOYSA-N xipamide Chemical compound CC1=CC=CC(C)=C1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1O MTZBBNMLMNBNJL-UHFFFAOYSA-N 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1